
BioUtah, Life Sciences Innovators Take Stage at Legislature’s Interim Meeting
September 21, 2023


The Utah Life Sciences Innovation Caucus, a bipartisan group of state legislators working to advance our life sciences industry and improving healthcare, hosted a lunch for all legislators during the September 18 interim meeting held in St. George. The caucus event, attended by all legislators from the House and Senate as well as staff provided an opportunity for lawmakers to learn not only about the industry in general in Utah, but also its impact in Southern Utah. The event was kicked off by comments about the industry and the Caucus by Senate President Stuart Adams, House Majority Whip, Jefferson Moss and Senate Majority Whip, Ann Millner.
Dr. Howard McLeod and Associate Dean, Aaron Davis, presented how funding from the legislature was key to establishing the Center for Precision Medicine and Functional Genomics making Utah Tech a center of excellence in this field. Their presentation was followed by a panel of eight life sciences companies from the St. George area moderated by Kelvyn Cullimore, CEO of BioUtah.
Panelists included:
- Lincoln Nadauld, Culmination Bio
- Mark Gubler, Deseret Labs
- Greg Prince, Soft Cell Bio Labs
- Cody Ballantyne, Forward Motion
- Seth Campbell, BioFi
- Jeremy Bradley, CathTip
- Scott Madsen, Birch OS
- Whitney Mason, Intermountain Precision Genomics
“The Life Sciences Innovation Caucus has become a unique opportunity to educate lawmakers about the important work we do and the contributions our industry makes to driving the Utah economy,” said Cullimore.
Recent News
- RefloDx Closes $2 Million Seed Round to Advance Noninvasive Testing for Chronic Throat and Voice Symptoms
- Myriad Genetics Releases New MONSTAR-SCREEN-3 Data Demonstrating the Potential of Ultra-Sensitive MRD Detection in Colorectal and Pancreatic Cancers
- Ultragenyx sells second rare pediatric PRV in a week for $203M
- Co-Diagnostics’ Joint Venture CoMira Diagnostics Invited by Saudi Ministry to Participate in Strategic Manufacturing Forum
- Route 92 Medical Announces $100 Million Corporate Debt Facility
- Myriad Genetics and Labcorp Announce Definitive Agreement for Myriad to Sell Prenatal Health Testing Business to Labcorp

















